熱門資訊> 正文
2025-03-19 04:51
CARGO Therapeutics (NASDAQ:CRGX) shares rose after market hours as the company announced a 90% workforce reduction along with suspending development of both CRG-023 and the company's allogeneic platform.
CRGX stock is up about 15% after the bell.
The company said that its Board has decided to suspend development efforts of both CRG-023 and CARGO’s allogeneic platform. It has also appointed Anup Radhakrishnan as interim CEO.
CARGO said that it had cash, cash equivalents and marketable securities of $368.1M as of December 31, 2024.